Event Details
|
|
|||||||
INVESTORS
& MEDIA
- Our Focus
We’re dedicated to the research and development of therapies for people suffering from debilitating diseases that rob them of key muscle functions.
- Pipeline
We’re advancing muscle biology-driven treatments for diseases characterized by compromised muscle function, muscle weakness, and fatigue.
- Clinical Trials
We have conducted more than 50 clinical trials as we strive to bring important new medicines to patients with diseases like ALS, heart failure, and SMA.
- Company
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators.
- Investors & Media
Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance.
INVESTORS